10-Q/A XBRL

10-Q/A

Company: Xenon Pharmaceuticals Inc.
Filed: May 26, 2020
Period of Report: March 31, 2020
Accession Number: 0001564590-20-026807

View Document ↗ View on SEC.gov ↗